// App-Quantinova.ai

4054 : Betablockers and outcomes in stable coronary artery disease. Insights from the CLARIFY registry

Researchers

Presenter

  • E Sorbets

Principal Investigators

  • R Young

  • N Danchin

  • N Greenlow

  • I Ford

  • M Tendera

  • R Ferrari

  • J C Tardif

  • K M Fox

  • P G Steg

Medical Centers

  • Hospital Avicenne of Bobigny, Cardiology, Bobigny, France

  • University of Glasgow, Robertson Centre for Biostatistics, Glasgow, United Kingdom

  • European Hospital Georges Pompidou, Centre IPC, Paris, France

  • Medical University of Silesia, Division of Cardiology and Structural Heart Diseases, Katowice, Poland

  • University Hospital of Ferrara, Cardiology and LTTA centre, Ferrara, Italy

  • Montreal Heart Institute, Internal Medicine and Cardiology, Montreal, Canada

  • Faculty of Medicine, Imperial College London, National Heart and Lung Institute, London, United Kingdom,

  • Hospital Bichat-Claude Bernard, Cardiology, FACT, and Paris 7 University, Paris, France

Locations

  • France

  • United Kingdom

  • Poland

  • Italy

  • Canada

Companies

  • N/A

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

Disease

  • N/A

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A


Study Design

  • Observational

  • Cohort

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A